| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | SOX3 FOXO1 TFEB SOX11 CSRNP1 TBX3 KMT2D BARHL2 ETV5 ZNF395 MEF2D GLIS1 | 1.11e-05 | 560 | 93 | 12 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | SOX3 FOXO1 TFEB SOX11 CSRNP1 TBX3 KMT2D BARHL2 ETV5 ZNF395 MEF2D GLIS1 | 1.23e-05 | 566 | 93 | 12 | GO:0001216 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX3 FOXO1 TFEB SOX11 CSRNP1 TBX3 POU6F2 CUX2 KMT2D GLI3 BARHL2 ZBTB4 YLPM1 PDX1 ETV5 ZNF395 BHLHE40 MEF2D GLIS1 | 2.28e-05 | 1412 | 93 | 19 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX3 FOXO1 TFEB SOX11 TBX3 POU6F2 CUX2 RBL1 GLI3 BARHL2 ZBTB4 PER1 PDX1 ETV5 ZNF395 BHLHE40 MEF2D GLIS1 | 1.19e-04 | 1459 | 93 | 18 | GO:0000977 |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.46e-04 | 120 | 93 | 5 | GO:0008013 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX3 FOXO1 TFEB SOX11 TBX3 POU6F2 CUX2 GLI3 ZBTB4 PER1 PDX1 ZNF395 BHLHE40 MEF2D GLIS1 | 6.02e-04 | 1244 | 93 | 15 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 7.42e-04 | 320 | 93 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX3 FOXO1 TFEB SOX11 TBX3 POU6F2 CUX2 GLI3 ZBTB4 PER1 PDX1 ZNF395 BHLHE40 MEF2D GLIS1 | 7.52e-04 | 1271 | 93 | 15 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 8.27e-04 | 326 | 93 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | poly(G) binding | 9.42e-04 | 10 | 93 | 2 | GO:0034046 | |
| GeneOntologyMolecularFunction | G-quadruplex RNA binding | 9.42e-04 | 10 | 93 | 2 | GO:0002151 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX3 FOXO1 SOX11 TBX3 CUX2 ATN1 RBL1 GLI3 ZBTB4 YLPM1 CPEB3 PER1 PDX1 ETV5 SMARCC2 BHLHE40 GLIS1 | 3.07e-06 | 1053 | 91 | 17 | GO:0000122 |
| GeneOntologyBiologicalProcess | postsynapse organization | 1.00e-05 | 313 | 91 | 9 | GO:0099173 | |
| GeneOntologyBiologicalProcess | neuron projection development | SPTBN4 DLG5 CUX2 ARHGEF40 PSD SEMA6D GLI3 BARHL2 ITSN1 CPEB3 AUTS2 PUM2 SRCIN1 KIF5A ULK1 RERE UST PLXNB3 | 1.08e-05 | 1285 | 91 | 18 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 1.79e-05 | 185 | 91 | 7 | GO:0099175 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SPTBN4 CUX2 ARHGEF40 SEMA6D GLI3 BARHL2 AUTS2 SRCIN1 KIF5A ULK1 RERE UST PLXNB3 | 2.39e-05 | 748 | 91 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 3.14e-05 | 202 | 91 | 7 | GO:0051963 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX3 FOXO1 SOX11 TBX3 CUX2 ATN1 RBL1 GLI3 ZBTB4 YLPM1 CPEB3 PER1 PDX1 ETV5 SMARCC2 RERE BHLHE40 GLIS1 | 3.38e-05 | 1399 | 91 | 18 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX3 FOXO1 SOX11 TBX3 CUX2 ATN1 RBL1 GLI3 ZBTB4 YLPM1 CPEB3 PER1 PDX1 ETV5 SMARCC2 RERE BHLHE40 GLIS1 | 3.86e-05 | 1413 | 91 | 18 | GO:1902679 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SPTBN4 CUX2 ARHGEF40 SEMA6D GLI3 BARHL2 AUTS2 SRCIN1 KIF5A ULK1 RERE UST PLXNB3 | 4.91e-05 | 802 | 91 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 5.31e-05 | 387 | 91 | 9 | GO:0050807 | |
| GeneOntologyBiologicalProcess | neuron development | SPTBN4 DLG5 CUX2 ARHGEF40 PSD SEMA6D GLI3 BARHL2 ITSN1 CPEB3 AUTS2 PUM2 SRCIN1 KIF5A ULK1 RERE UST PLXNB3 | 6.07e-05 | 1463 | 91 | 18 | GO:0048666 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SPTBN4 CUX2 ARHGEF40 SEMA6D GLI3 BARHL2 AUTS2 SRCIN1 KIF5A ULK1 RERE UST PLXNB3 | 6.08e-05 | 819 | 91 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 6.21e-05 | 395 | 91 | 9 | GO:0050803 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SPTBN4 CUX2 ARHGEF40 SEMA6D GLI3 BARHL2 AUTS2 SRCIN1 KIF5A ULK1 RERE UST PLXNB3 | 6.63e-05 | 826 | 91 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell junction organization | SPTBN4 DLG5 CUX2 CDH22 PSD CASKIN1 ITSN1 FBF1 CPEB3 ETV5 PTPN23 SRCIN1 TNS1 ZDHHC8 | 8.96e-05 | 974 | 91 | 14 | GO:0034330 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SOX3 FOXO1 TFEB SOX11 BCL9L CSRNP1 TBX3 KMT2D GLI3 BARHL2 PER1 PDX1 AUTS2 ETV5 ZNF395 MEF2D GLIS1 | 1.08e-04 | 1390 | 91 | 17 | GO:0045944 |
| GeneOntologyBiologicalProcess | axon development | SPTBN4 ARHGEF40 SEMA6D GLI3 BARHL2 AUTS2 PUM2 KIF5A ULK1 UST PLXNB3 | 1.21e-04 | 642 | 91 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | axonogenesis | SPTBN4 ARHGEF40 SEMA6D GLI3 BARHL2 AUTS2 KIF5A ULK1 UST PLXNB3 | 1.96e-04 | 566 | 91 | 10 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell junction assembly | 2.04e-04 | 569 | 91 | 10 | GO:0034329 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | SPTBN4 PATL2 DLG5 CUX2 PSD CASKIN1 CPEB3 KANK4 AUTS2 SRCIN1 ULK1 ATG2A ZDHHC8 SLX4 PLXNB3 | 2.08e-04 | 1189 | 91 | 15 | GO:0044087 |
| GeneOntologyBiologicalProcess | cell morphogenesis | SPTBN4 BCL9L CUX2 CDH22 ARHGEF40 SEMA6D GLI3 BARHL2 AUTS2 SRCIN1 KIF5A ULK1 RERE UST PLXNB3 | 2.18e-04 | 1194 | 91 | 15 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 2.60e-04 | 70 | 91 | 4 | GO:0060999 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 4.03e-04 | 141 | 91 | 5 | GO:0060996 | |
| GeneOntologyBiologicalProcess | synapse assembly | 4.29e-04 | 308 | 91 | 7 | GO:0007416 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 4.30e-04 | 625 | 91 | 10 | GO:0051960 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 4.37e-04 | 309 | 91 | 7 | GO:1901888 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 4.49e-04 | 515 | 91 | 9 | GO:0050767 | |
| GeneOntologyCellularComponent | nuclear body | SPTBN4 SRRT FAM193B GLI3 ZBTB4 YLPM1 TOPBP1 PDX1 PTPN23 ZNF395 PATL1 RERE KMT2E BHLHE40 | 3.44e-05 | 903 | 91 | 14 | GO:0016604 |
| GeneOntologyCellularComponent | chromatin | SOX3 FOXO1 TFEB SOX11 CSRNP1 TBX3 POU6F2 CUX2 RBL1 BICRA BARHL2 PDX1 ETV5 SMARCC2 KMT2E BHLHE40 MEF2D SLX4 | 5.93e-05 | 1480 | 91 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | apical dendrite | 3.61e-04 | 32 | 91 | 3 | GO:0097440 | |
| HumanPheno | Poor suck | 9.86e-06 | 152 | 27 | 7 | HP:0002033 | |
| HumanPheno | Aplasia of the 4th metacarpal | 2.71e-05 | 2 | 27 | 2 | HP:0010043 | |
| HumanPheno | Small nail | 3.32e-05 | 183 | 27 | 7 | HP:0001792 | |
| HumanPheno | Atrial septal defect | SOX11 DPH2 DLG5 KMT2D ATN1 BICRA GLI3 AUTS2 SMARCC2 RERE SLX4 | 4.66e-05 | 541 | 27 | 11 | HP:0001631 |
| HumanPheno | Abnormality of the atrial septum | SOX11 DPH2 DLG5 KMT2D ATN1 BICRA GLI3 AUTS2 SMARCC2 RERE SLX4 | 4.66e-05 | 541 | 27 | 11 | HP:0001630 |
| HumanPheno | Abnormal atrial septum morphology | SOX11 DPH2 DLG5 KMT2D ATN1 BICRA GLI3 AUTS2 SMARCC2 RERE SLX4 | 4.91e-05 | 544 | 27 | 11 | HP:0011994 |
| HumanPheno | Cryptorchidism | SOX3 SOX11 TBX3 POU6F2 KMT2D ATN1 BICRA GLI3 AUTS2 SMARCC2 RERE KMT2E SLX4 | 5.72e-05 | 780 | 27 | 13 | HP:0000028 |
| HumanPheno | Prominent eyelashes | 8.60e-05 | 17 | 27 | 3 | HP:0011231 | |
| HumanPheno | Horseshoe kidney | 1.01e-04 | 149 | 27 | 6 | HP:0000085 | |
| HumanPheno | Inverted nipples | 1.22e-04 | 50 | 27 | 4 | HP:0003186 | |
| HumanPheno | Abnormal cardiac atrium morphology | SOX11 DPH2 DLG5 KMT2D ATN1 BICRA GLI3 AUTS2 SMARCC2 RERE SLX4 | 1.57e-04 | 617 | 27 | 11 | HP:0005120 |
| HumanPheno | Low hanging columella | 1.91e-04 | 56 | 27 | 4 | HP:0009765 | |
| HumanPheno | Abnormal localization of kidney | 1.91e-04 | 241 | 27 | 7 | HP:0100542 | |
| HumanPheno | Aplasia/Hypoplasia of the nails | 2.92e-04 | 258 | 27 | 7 | HP:0008386 | |
| HumanPheno | Abnormal spermatogenesis | SOX3 SOX11 DPH2 PATL2 TBX3 POU6F2 KMT2D ATN1 BICRA GLI3 AUTS2 SMARCC2 RERE KMT2E SLX4 | 2.96e-04 | 1190 | 27 | 15 | HP:0008669 |
| HumanPheno | Abnormal cardiac septum morphology | SOX11 DPH2 TBX3 DLG5 KMT2D ATN1 BICRA GLI3 AUTS2 SMARCC2 RERE SLX4 | 3.12e-04 | 787 | 27 | 12 | HP:0001671 |
| HumanPheno | Short 5th finger | 3.20e-04 | 64 | 27 | 4 | HP:0009237 | |
| HumanPheno | Tetralogy of Fallot | 3.31e-04 | 185 | 27 | 6 | HP:0001636 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 3.61e-04 | 66 | 27 | 4 | HP:0006262 | |
| HumanPheno | Abnormal male internal genitalia morphology | SOX3 SOX11 DPH2 PATL2 TBX3 POU6F2 KMT2D ATN1 BICRA GLI3 AUTS2 SMARCC2 RERE KMT2E SLX4 | 4.93e-04 | 1243 | 27 | 15 | HP:0000022 |
| HumanPheno | Abnormal cheek morphology | 5.03e-04 | 282 | 27 | 7 | HP:0004426 | |
| HumanPheno | Hypospadias | 5.30e-04 | 377 | 27 | 8 | HP:0000047 | |
| HumanPheno | Feeding difficulties in infancy | SPTBN4 SOX11 KMT2D SH3BP2 AUTS2 SMARCC2 PTPN23 NUP214 KIF5A RERE | 5.70e-04 | 594 | 27 | 10 | HP:0008872 |
| HumanPheno | Cerebellar malformation | 6.03e-04 | 487 | 27 | 9 | HP:0002438 | |
| HumanPheno | Abnormal nasal tip morphology | 6.21e-04 | 386 | 27 | 8 | HP:0000436 | |
| HumanPheno | Functional abnormality of male internal genitalia | SOX3 SOX11 DPH2 PATL2 TBX3 POU6F2 KMT2D ATN1 BICRA GLI3 AUTS2 SMARCC2 RERE KMT2E SLX4 | 6.26e-04 | 1269 | 27 | 15 | HP:0000025 |
| HumanPheno | Abnormal testis morphology | SOX3 SOX11 DPH2 TBX3 POU6F2 KMT2D ATN1 BICRA GLI3 AUTS2 SMARCC2 RERE KMT2E SLX4 | 6.75e-04 | 1129 | 27 | 14 | HP:0000035 |
| HumanPheno | Non-obstructive azoospermia | SOX3 SOX11 DPH2 TBX3 POU6F2 KMT2D ATN1 BICRA GLI3 AUTS2 SMARCC2 RERE KMT2E SLX4 | 6.94e-04 | 1132 | 27 | 14 | HP:0011961 |
| HumanPheno | Noncommunicating hydrocephalus | 7.43e-04 | 8 | 27 | 2 | HP:0010953 | |
| HumanPheno | Dandy-Walker malformation | 7.47e-04 | 141 | 27 | 5 | HP:0001305 | |
| HumanPheno | Displacement of the urethral meatus | 7.50e-04 | 397 | 27 | 8 | HP:0100627 | |
| HumanPheno | Abnormality of central nervous system electrophysiology | SPTBN4 SOX11 DPH2 CUX2 KMT2D ATN1 GLI3 SMARCC2 PTPN23 KIF5A RERE | 7.75e-04 | 738 | 27 | 11 | HP:0030178 |
| HumanPheno | Abnormal male urethral meatus morphology | 7.76e-04 | 399 | 27 | 8 | HP:0032076 | |
| HumanPheno | Dolichocephaly | 8.16e-04 | 219 | 27 | 6 | HP:0000268 | |
| HumanPheno | Hypoplastic toenails | 8.26e-04 | 82 | 27 | 4 | HP:0001800 | |
| HumanPheno | Ventricular septal defect | 8.46e-04 | 510 | 27 | 9 | HP:0001629 | |
| HumanPheno | Abnormal posterior cranial fossa morphology | 8.56e-04 | 221 | 27 | 6 | HP:0000932 | |
| HumanPheno | Azoospermia | SOX3 SOX11 DPH2 TBX3 POU6F2 KMT2D ATN1 BICRA GLI3 AUTS2 SMARCC2 RERE KMT2E SLX4 | 8.77e-04 | 1157 | 27 | 14 | HP:0000027 |
| HumanPheno | Renal hypoplasia | 9.03e-04 | 147 | 27 | 5 | HP:0000089 | |
| HumanPheno | Giant somatosensory evoked potentials | 9.03e-04 | 147 | 27 | 5 | HP:0001312 | |
| HumanPheno | Abnormal nail morphology | 9.22e-04 | 516 | 27 | 9 | HP:0001597 | |
| HumanPheno | Abnormal male reproductive system physiology | SOX3 SOX11 DPH2 PATL2 TBX3 POU6F2 KMT2D ATN1 BICRA GLI3 AUTS2 SMARCC2 RERE KMT2E SLX4 | 9.32e-04 | 1314 | 27 | 15 | HP:0012874 |
| HumanPheno | Abnormal ventricular septum morphology | 9.89e-04 | 521 | 27 | 9 | HP:0010438 | |
| MousePheno | reduced female fertility | 5.49e-06 | 296 | 78 | 10 | MP:0001923 | |
| Domain | PAT1 | 2.25e-05 | 2 | 89 | 2 | PF09770 | |
| Domain | Topo_II-assoc_PAT1 | 2.25e-05 | 2 | 89 | 2 | IPR019167 | |
| Domain | Atrophin-like | 2.25e-05 | 2 | 89 | 2 | IPR002951 | |
| Domain | Atrophin-1 | 2.25e-05 | 2 | 89 | 2 | PF03154 | |
| Domain | Sema | 4.27e-04 | 31 | 89 | 3 | SM00630 | |
| Domain | Semap_dom | 4.27e-04 | 31 | 89 | 3 | IPR001627 | |
| Domain | Sema | 4.27e-04 | 31 | 89 | 3 | PF01403 | |
| Domain | SEMA | 4.27e-04 | 31 | 89 | 3 | PS51004 | |
| Domain | PSI | 4.69e-04 | 32 | 89 | 3 | PF01437 | |
| Domain | Plexin_repeat | 4.69e-04 | 32 | 89 | 3 | IPR002165 | |
| Domain | PH_dom-spectrin-type | 7.91e-04 | 9 | 89 | 2 | IPR001605 | |
| Domain | Homeodomain-like | 1.04e-03 | 332 | 89 | 7 | IPR009057 | |
| Domain | PSI | 1.20e-03 | 44 | 89 | 3 | IPR016201 | |
| Domain | PSI | 1.37e-03 | 46 | 89 | 3 | SM00423 | |
| Domain | HMG_box | 2.06e-03 | 53 | 89 | 3 | PF00505 | |
| Domain | PH | 2.13e-03 | 278 | 89 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 2.17e-03 | 279 | 89 | 6 | PS50003 | |
| Domain | HMG | 2.18e-03 | 54 | 89 | 3 | SM00398 | |
| Domain | PH_domain | 2.21e-03 | 280 | 89 | 6 | IPR001849 | |
| Domain | - | 2.29e-03 | 55 | 89 | 3 | 1.10.30.10 | |
| Domain | - | 2.64e-03 | 391 | 89 | 7 | 2.30.29.30 | |
| Domain | HMG_box_dom | 3.69e-03 | 65 | 89 | 3 | IPR009071 | |
| Domain | SH3 | 3.73e-03 | 216 | 89 | 5 | SM00326 | |
| Domain | SH3 | 3.73e-03 | 216 | 89 | 5 | PS50002 | |
| Domain | SH3_domain | 4.04e-03 | 220 | 89 | 5 | IPR001452 | |
| Domain | PH_dom-like | 4.23e-03 | 426 | 89 | 7 | IPR011993 | |
| Domain | PH | 4.78e-03 | 229 | 89 | 5 | PF00169 | |
| Domain | Znf_FYVE_PHD | 5.36e-03 | 147 | 89 | 4 | IPR011011 | |
| Domain | PHD | 5.52e-03 | 75 | 89 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 6.37e-03 | 79 | 89 | 3 | IPR019787 | |
| Domain | SANT_dom | 6.77e-03 | 26 | 89 | 2 | IPR017884 | |
| Domain | IPT | 7.29e-03 | 27 | 89 | 2 | SM00429 | |
| Domain | - | 7.29e-03 | 27 | 89 | 2 | 1.10.260.40 | |
| Domain | SANT | 7.83e-03 | 28 | 89 | 2 | PS51293 | |
| Domain | BRCT_dom | 7.83e-03 | 28 | 89 | 2 | IPR001357 | |
| Domain | Nucleotide-bd_a/b_plait | 7.83e-03 | 258 | 89 | 5 | IPR012677 | |
| Domain | C2_dom | 7.85e-03 | 164 | 89 | 4 | IPR000008 | |
| Domain | SH3_2 | 8.05e-03 | 86 | 89 | 3 | IPR011511 | |
| Domain | SH3_2 | 8.05e-03 | 86 | 89 | 3 | PF07653 | |
| Domain | Lambda_DNA-bd_dom | 8.38e-03 | 29 | 89 | 2 | IPR010982 | |
| Domain | PHD | 8.84e-03 | 89 | 89 | 3 | SM00249 | |
| Domain | Znf_PHD | 9.40e-03 | 91 | 89 | 3 | IPR001965 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MST1R TFEB DPH2 FAM193B MYOF ARHGEF40 KMT2D BICRA CASKIN1 ZBTB4 PER1 C15orf39 NUP214 ZNF395 ULK1 TNFAIP3 ATG2A MBD6 ZDHHC8 WNK2 PKN3 C6orf132 CABLES1 | 2.66e-14 | 1105 | 96 | 23 | 35748872 |
| Pubmed | BCL9L SRRT KMT2D FAM120A ATN1 RBM33 BICRA GLI3 SEC24A YLPM1 AUTS2 ETV5 PUM2 C15orf39 SMARCC2 NUP214 PATL1 RERE MBD6 MEF2D SLX4 CPSF7 | 3.92e-11 | 1429 | 96 | 22 | 35140242 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DOCK5 CUX2 ATN1 SPATA31E1 BICRA ITSN1 YLPM1 RNF38 NUP214 ATG2A KMT2E WNK2 C6orf132 | 2.10e-10 | 430 | 96 | 13 | 35044719 |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L TBX3 KMT2D ATN1 BICRA AUTS2 C15orf39 SMARCC2 NUP214 RERE MBD6 SLX4 | 2.71e-10 | 351 | 96 | 12 | 38297188 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX3 FOXO1 TFEB SOX11 TBX3 POU6F2 CUX2 KMT2D GLI3 BARHL2 ZBTB4 PDX1 ZNF395 RERE BHLHE40 MEF2D GLIS1 | 4.74e-10 | 908 | 96 | 17 | 19274049 |
| Pubmed | TBX3 RBM33 BICRA ITSN1 PTPN23 NUP214 KIF5A TNFAIP3 BHLHE40 TNS1 MEF2D WNK2 MAP3K4 | 9.30e-10 | 486 | 96 | 13 | 20936779 | |
| Pubmed | BCL9L KMT2D ATN1 RBM33 U2SURP YLPM1 SMARCC2 RERE MEF2D CPSF7 | 3.93e-09 | 268 | 96 | 10 | 33640491 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRT MYOF KMT2D ATN1 ITSN1 YLPM1 PUM2 SMARCC2 TJAP1 NUP214 PATL1 PROSER2 RERE MEF2D | 2.89e-08 | 774 | 96 | 14 | 15302935 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L KMT2D ATN1 RBM33 SEC24A YLPM1 AUTS2 PUM2 NUP214 MEF2D CPSF7 | 5.79e-08 | 457 | 96 | 11 | 32344865 |
| Pubmed | 2.87e-07 | 233 | 96 | 8 | 37704626 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | SOX3 TFEB TBX3 CUX2 GLI3 BARHL2 PDX1 ETV5 BHLHE40 MEF2D GLIS1 | 3.30e-07 | 544 | 96 | 11 | 28473536 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | SPTBN4 SRRT ATN1 ITSN1 FBF1 PLEKHA4 SMARCC2 TJAP1 KIF5A BHLHE40 PPP1R12C | 4.39e-07 | 560 | 96 | 11 | 21653829 |
| Pubmed | 1.99e-06 | 407 | 96 | 9 | 12693553 | ||
| Pubmed | Spindle Assembly Checkpoint Inhibition Can Resensitize p53-Null Stem Cells to Cancer Chemotherapy. | 2.32e-06 | 137 | 96 | 6 | 30862715 | |
| Pubmed | EP400P1 TBX3 ARHGEF40 FAM120A PSD ATN1 RBL1 BICRA GLI3 SH3BP2 FBF1 PER1 SMARCC2 RERE | 2.34e-06 | 1116 | 96 | 14 | 31753913 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.72e-06 | 220 | 96 | 7 | 35785414 | |
| Pubmed | 4.23e-06 | 152 | 96 | 6 | 38360978 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | FOXO1 TFEB SRRT RBM33 SEC24A SH3BP2 PER1 C15orf39 TJAP1 PATL1 PROSER2 ATG2A MEF2D | 5.66e-06 | 1038 | 96 | 13 | 26673895 |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25030699 | ||
| Pubmed | Advanced glycation end-products affect transcription factors regulating insulin gene expression. | 7.54e-06 | 2 | 96 | 2 | 20353756 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 10814707 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 26727107 | ||
| Pubmed | Identification of PatL1, a human homolog to yeast P body component Pat1. | 7.54e-06 | 2 | 96 | 2 | 17936923 | |
| Pubmed | Altered expression of MLL methyltransferase family genes in breast cancer. | 7.54e-06 | 2 | 96 | 2 | 23754336 | |
| Pubmed | Identification of a conserved interface between PUF and CPEB proteins. | 7.54e-06 | 2 | 96 | 2 | 22496444 | |
| Pubmed | 8.77e-06 | 263 | 96 | 7 | 34702444 | ||
| Pubmed | DOCK5 SRRT TBX3 ARHGEF40 FAM120A ATN1 RBL1 C15orf39 PATL1 ULK1 | 1.29e-05 | 650 | 96 | 10 | 38777146 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KLHL29 SPTBN4 DOCK5 EP400P1 POU6F2 FAM120A BICRA SH3BP2 AUTS2 TJAP1 SRCIN1 PATL1 RERE GLIS1 WNK2 | 1.39e-05 | 1489 | 96 | 15 | 28611215 |
| Pubmed | SPTBN4 FAM120A PRR36 CASKIN1 ITSN1 YLPM1 SMARCC2 TJAP1 RIMBP2 KIF5A TNS1 WNK2 | 1.40e-05 | 963 | 96 | 12 | 28671696 | |
| Pubmed | 1.61e-05 | 18 | 96 | 3 | 14645126 | ||
| Pubmed | A multistate stem cell dynamics maintains homeostasis in mouse spermatogenesis. | 1.91e-05 | 19 | 96 | 3 | 34686326 | |
| Pubmed | Genetic interaction of Per1 and Dec1/2 in the regulation of circadian locomotor activity. | 2.26e-05 | 3 | 96 | 2 | 22215611 | |
| Pubmed | Regulation of Tbx3 expression by anteroposterior signalling in vertebrate limb development. | 2.26e-05 | 3 | 96 | 2 | 12376101 | |
| Pubmed | Sequentially acting Sox transcription factors in neural lineage development. | 2.26e-05 | 3 | 96 | 2 | 22085726 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 19131340 | ||
| Pubmed | TFEB Transcriptional Responses Reveal Negative Feedback by BHLHE40 and BHLHE41. | 2.26e-05 | 3 | 96 | 2 | 33176151 | |
| Pubmed | 2.42e-05 | 425 | 96 | 8 | 24999758 | ||
| Pubmed | Expression of Sox transcription factors in the developing mouse pancreas. | 2.61e-05 | 21 | 96 | 3 | 12815626 | |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 2.67e-05 | 431 | 96 | 8 | 33660365 | |
| Pubmed | 2.71e-05 | 126 | 96 | 5 | 16284245 | ||
| Pubmed | 3.14e-05 | 130 | 96 | 5 | 12421765 | ||
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 3.69e-05 | 329 | 96 | 7 | 34316702 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 3.73e-05 | 588 | 96 | 9 | 38580884 | |
| Pubmed | SPTBN4 SRRT FAM120A PRR36 CRACDL CASKIN1 ITSN1 SMARCC2 RIMBP2 SRCIN1 TNS1 WNK2 PPP1R12C CPSF7 | 3.82e-05 | 1431 | 96 | 14 | 37142655 | |
| Pubmed | Identification of the human testis protein phosphatase 1 interactome. | 3.88e-05 | 68 | 96 | 4 | 21382349 | |
| Pubmed | 4.49e-05 | 25 | 96 | 3 | 27046536 | ||
| Pubmed | Distinct functions of maternal and somatic Pat1 protein paralogs. | 4.51e-05 | 4 | 96 | 2 | 20826699 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 19837872 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 19799567 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 14722613 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 17150957 | ||
| Pubmed | Dec1 and Dec2 expression is disrupted in the suprachiasmatic nuclei of Clock mutant mice. | 4.51e-05 | 4 | 96 | 2 | 15038852 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 12219087 | ||
| Pubmed | DOCK5 VPS37C SRRT ARHGEF40 PRR36 RBM33 RBL1 ITSN1 SMARCC2 NUP214 PKN3 | 4.58e-05 | 916 | 96 | 11 | 32203420 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 4.64e-05 | 232 | 96 | 6 | 25515538 | |
| Pubmed | 5.07e-05 | 472 | 96 | 8 | 38943005 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SRRT RBM33 BICRA U2SURP YLPM1 TOPBP1 SMARCC2 NUP214 MEF2D SLX4 CPSF7 | 6.59e-05 | 954 | 96 | 11 | 36373674 |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 6.97e-05 | 364 | 96 | 7 | 24778252 | |
| Pubmed | 7.17e-05 | 251 | 96 | 6 | 29031500 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 16289749 | ||
| Pubmed | TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex. | 7.50e-05 | 5 | 96 | 2 | 32808927 | |
| Pubmed | Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding. | 7.50e-05 | 5 | 96 | 2 | 15256501 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 18026121 | ||
| Pubmed | Interplay between scatter factor receptors and B plexins controls invasive growth. | 7.50e-05 | 5 | 96 | 2 | 15184888 | |
| Pubmed | DEC1 modulates the circadian phase of clock gene expression. | 7.50e-05 | 5 | 96 | 2 | 18411297 | |
| Pubmed | 8.08e-05 | 808 | 96 | 10 | 20412781 | ||
| Pubmed | 1.12e-04 | 529 | 96 | 8 | 14621295 | ||
| Pubmed | Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. | 1.12e-04 | 6 | 96 | 2 | 16356933 | |
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 33895473 | ||
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 7821514 | ||
| Pubmed | A novel gene, GliH1, with homology to the Gli zinc finger domain not required for mouse development. | 1.12e-04 | 6 | 96 | 2 | 12385751 | |
| Pubmed | IRIZIO: a novel gene cooperating with PAX3-FOXO1 in alveolar rhabdomyosarcoma (ARMS). | 1.12e-04 | 6 | 96 | 2 | 21177767 | |
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 18665267 | ||
| Pubmed | Expression of two type II cadherins, Cdh12 and Cdh22 in the developing and adult mouse brain. | 1.12e-04 | 6 | 96 | 2 | 20723620 | |
| Pubmed | Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease. | 1.15e-04 | 34 | 96 | 3 | 25915474 | |
| Pubmed | A multipotent progenitor domain guides pancreatic organogenesis. | 1.21e-04 | 91 | 96 | 4 | 17609113 | |
| Pubmed | 1.23e-04 | 399 | 96 | 7 | 35987950 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO1 TFEB SRRT DLG5 SEC24A TNFAIP3 PROSER2 MEF2D PPP1R12C C6orf132 | 1.36e-04 | 861 | 96 | 10 | 36931259 |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.47e-04 | 180 | 96 | 5 | 35198878 | |
| Pubmed | Interplay of SOX and POU factors in regulation of the Nestin gene in neural primordial cells. | 1.57e-04 | 7 | 96 | 2 | 15456859 | |
| Pubmed | Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors. | 1.57e-04 | 7 | 96 | 2 | 16481466 | |
| Pubmed | Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity. | 1.57e-04 | 7 | 96 | 2 | 22510986 | |
| Pubmed | Dec1 and Dec2 are regulators of the mammalian molecular clock. | 1.57e-04 | 7 | 96 | 2 | 12397359 | |
| Pubmed | 1.57e-04 | 7 | 96 | 2 | 12488434 | ||
| Pubmed | 1.57e-04 | 7 | 96 | 2 | 25100735 | ||
| Pubmed | An AUTS2-Polycomb complex activates gene expression in the CNS. | 1.60e-04 | 38 | 96 | 3 | 25519132 | |
| Pubmed | SRRT MYOF TBX3 DLG5 FAM120A ATN1 U2SURP SMARCC2 NUP214 PATL1 MEF2D CPSF7 | 1.67e-04 | 1247 | 96 | 12 | 27684187 | |
| Pubmed | 1.93e-04 | 191 | 96 | 5 | 24146773 | ||
| Pubmed | 1.98e-04 | 733 | 96 | 9 | 34672954 | ||
| Pubmed | 2.09e-04 | 8 | 96 | 2 | 15147242 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 2.09e-04 | 8 | 96 | 2 | 23130995 | |
| Pubmed | Enhancer redundancy provides phenotypic robustness in mammalian development. | 2.09e-04 | 8 | 96 | 2 | 29420474 | |
| Pubmed | Dynamic expression of Tbx2 and Tbx3 in developing mouse pancreas. | 2.09e-04 | 8 | 96 | 2 | 21867776 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DOCK5 TFEB SRRT TBX3 KMT2D U2SURP YLPM1 TOPBP1 NUP214 ZNF395 BHLHE40 CPSF7 | 2.34e-04 | 1294 | 96 | 12 | 30804502 |
| Pubmed | 2.68e-04 | 9 | 96 | 2 | 24449572 | ||
| Pubmed | 2.68e-04 | 9 | 96 | 2 | 37805104 | ||
| Pubmed | UBAP1 is a component of an endosome-specific ESCRT-I complex that is essential for MVB sorting. | 2.68e-04 | 9 | 96 | 2 | 21757351 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 3.01e-04 | 462 | 96 | 7 | 31138677 | |
| Pubmed | Identification of NPM-ALK interacting proteins by tandem mass spectrometry. | 3.03e-04 | 47 | 96 | 3 | 14968112 | |
| Pubmed | 3.34e-04 | 10 | 96 | 2 | 10037800 | ||
| Interaction | TOP3B interactions | MST1R TFEB DPH2 FAM193B MYOF ARHGEF40 KMT2D FAM120A RBM33 BICRA SEC24A CASKIN1 ZBTB4 PLEKHA4 PER1 C15orf39 NUP214 ZNF395 PATL1 ULK1 TNFAIP3 ATG2A MBD6 ZDHHC8 WNK2 PKN3 C6orf132 CABLES1 | 6.67e-11 | 1470 | 94 | 28 | int:TOP3B |
| Interaction | SP7 interactions | BCL9L SRRT KMT2D ATN1 RBM33 BICRA YLPM1 C15orf39 SMARCC2 RERE MEF2D CPSF7 | 1.77e-08 | 304 | 94 | 12 | int:SP7 |
| Interaction | TLE3 interactions | SPTBN4 BCL9L SRRT TBX3 KMT2D ATN1 SEC24A ZBTB4 AUTS2 C15orf39 SMARCC2 RERE CPSF7 | 2.08e-08 | 376 | 94 | 13 | int:TLE3 |
| Interaction | GSC interactions | 1.65e-07 | 87 | 94 | 7 | int:GSC | |
| Interaction | NUP35 interactions | BCL9L KMT2D ATN1 RBM33 SEC24A YLPM1 PLEKHA4 AUTS2 PUM2 NUP214 MEF2D CPSF7 | 6.48e-07 | 424 | 94 | 12 | int:NUP35 |
| Interaction | ALG13 interactions | 2.27e-06 | 183 | 94 | 8 | int:ALG13 | |
| Interaction | AR interactions | FOXO1 BCL9L SRRT TBX3 KMT2D ATN1 RBM33 RBL1 GLI3 U2SURP YLPM1 ETV5 SMARCC2 RERE TNS1 MEF2D CPSF7 | 2.99e-06 | 992 | 94 | 17 | int:AR |
| Interaction | RBPMS interactions | VPS37C POU6F2 FAM120A ATN1 FBF1 PER1 SMARCC2 PATL1 BHLHE40 CPSF7 | 4.22e-06 | 340 | 94 | 10 | int:RBPMS |
| Interaction | TSG101 interactions | 1.21e-05 | 303 | 94 | 9 | int:TSG101 | |
| Interaction | SPATA1 interactions | 1.27e-05 | 31 | 94 | 4 | int:SPATA1 | |
| Interaction | CRX interactions | 2.49e-05 | 254 | 94 | 8 | int:CRX | |
| Interaction | PAX9 interactions | 3.28e-05 | 130 | 94 | 6 | int:PAX9 | |
| Interaction | PRRC2B interactions | 3.37e-05 | 265 | 94 | 8 | int:PRRC2B | |
| Interaction | HDAC1 interactions | SRRT TBX3 KMT2D RBL1 GLI3 PLEKHA4 PDX1 C15orf39 SMARCC2 NUP214 ZNF395 RERE KMT2E BHLHE40 MEF2D PHF21B | 4.98e-05 | 1108 | 94 | 16 | int:HDAC1 |
| Interaction | RBFOX2 interactions | 5.50e-05 | 284 | 94 | 8 | int:RBFOX2 | |
| Interaction | BRIP1 interactions | 7.08e-05 | 92 | 94 | 5 | int:BRIP1 | |
| Interaction | ERG interactions | 8.37e-05 | 223 | 94 | 7 | int:ERG | |
| Interaction | KHSRP interactions | 9.69e-05 | 308 | 94 | 8 | int:KHSRP | |
| Interaction | EGR2 interactions | 1.50e-04 | 171 | 94 | 6 | int:EGR2 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.08e-04 | 206 | 64 | 5 | 682 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | SRRT KMT2D ATN1 RBM33 BICRA SH3BP2 NUP214 MEF2D PPP1R12C CPSF7 | 4.71e-07 | 338 | 96 | 10 | M17094 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | SRRT PATL2 MYOF RBM33 BICRA C15orf39 SMARCC2 TJAP1 ULK1 ATG2A MBD6 BHLHE40 ZDHHC8 MEF2D PPP1R12C | 1.01e-06 | 905 | 96 | 15 | M40865 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | SPTBN4 SOX11 FAM193B PSD RBM33 AUTS2 RIMBP2 SRCIN1 RERE PPP1R12C | 1.68e-06 | 389 | 96 | 10 | M39102 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | SRRT RBM33 BICRA SMARCC2 TJAP1 PATL1 ULK1 ATG2A MBD6 BHLHE40 ZDHHC8 MEF2D | 3.55e-06 | 634 | 96 | 12 | M40866 |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN | 6.51e-06 | 190 | 96 | 7 | M7317 | |
| Coexpression | GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 8.53e-06 | 198 | 96 | 7 | M5335 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 8.81e-06 | 199 | 96 | 7 | M7319 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 9.10e-06 | 200 | 96 | 7 | M291 | |
| Coexpression | GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN | 1.86e-05 | 149 | 96 | 6 | M6708 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 2.32e-05 | 155 | 96 | 6 | M8944 | |
| Coexpression | GRADE_COLON_VS_RECTAL_CANCER_DN | 5.36e-05 | 56 | 96 | 4 | M9435 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 8.35e-05 | 493 | 96 | 9 | M19391 | |
| Coexpression | GSE16266_CTRL_VS_LPS_STIM_MEF_UP | 9.08e-05 | 198 | 96 | 6 | M7219 | |
| Coexpression | GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 9.34e-05 | 199 | 96 | 6 | M5348 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 9.34e-05 | 199 | 96 | 6 | M6519 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN | 9.60e-05 | 200 | 96 | 6 | M7771 | |
| Coexpression | GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN | 9.60e-05 | 200 | 96 | 6 | M8574 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 1.62e-04 | 139 | 96 | 5 | M8948 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 186 | 96 | 6 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 187 | 96 | 6 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-06 | 187 | 96 | 6 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 187 | 96 | 6 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 187 | 96 | 6 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-gd_T|COVID-19_Mild / Disease group, lineage and cell class | 4.49e-06 | 198 | 96 | 6 | 6aea5d00c417708f05b6d2dfe5a962d80864f8eb | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 4.76e-06 | 200 | 96 | 6 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 4.76e-06 | 200 | 96 | 6 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.76e-06 | 200 | 96 | 6 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Krt80|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.37e-05 | 141 | 96 | 5 | 40ef6d792e11fe10963d64eb0b606b90556c1a70 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Trm_gut_CD8|blood / Manually curated celltypes from each tissue | 1.97e-05 | 152 | 96 | 5 | 1fea735321da6db6d2cd3f83d2f7fac72d44904d | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.23e-05 | 156 | 96 | 5 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.18e-05 | 168 | 96 | 5 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 168 | 96 | 5 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-05 | 169 | 96 | 5 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.27e-05 | 169 | 96 | 5 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.27e-05 | 169 | 96 | 5 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.07e-05 | 177 | 96 | 5 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | IIF-Lymphocyte-T_NK-MAIT|IIF / Disease, Lineage and Cell Type | 4.19e-05 | 178 | 96 | 5 | be777ebef8f09a1a16fcee8fc69a65ab295b6e1d | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 4.19e-05 | 178 | 96 | 5 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.65e-05 | 182 | 96 | 5 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 183 | 96 | 5 | 25c96df8ea0c7bbedbb7699ee84ad6234d19cba8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 184 | 96 | 5 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 185 | 96 | 5 | dbbd348714cd16a4948a04648e914b1e71e2a8ef | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 185 | 96 | 5 | bea69058afa5aa927fe15c1f8d46460562ec4dd4 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.29e-05 | 187 | 96 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.29e-05 | 187 | 96 | 5 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.29e-05 | 187 | 96 | 5 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 96 | 5 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 5.43e-05 | 188 | 96 | 5 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 189 | 96 | 5 | 6c71e81373cb7822de23c193a6350b6df9f567bc | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 189 | 96 | 5 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-05 | 190 | 96 | 5 | 5c64b727669b23d2a23c8ad1d5d6caab7af37d56 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-05 | 190 | 96 | 5 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-05 | 190 | 96 | 5 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-05 | 190 | 96 | 5 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-05 | 192 | 96 | 5 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.30e-05 | 194 | 96 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.30e-05 | 194 | 96 | 5 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | mild_COVID-19-CD4+_CTL|World / disease group, cell group and cell class (v2) | 6.45e-05 | 195 | 96 | 5 | 980909246c30471c9f2f97c3b20b6d6d20fe574e | |
| ToppCell | mild_COVID-19|World / disease group, cell group and cell class (v2) | 6.45e-05 | 195 | 96 | 5 | 6dbe9db5f0e94f2e91b3d1282855d200051ab0ba | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.45e-05 | 195 | 96 | 5 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Trm_Th1/Th17|Liver / Manually curated celltypes from each tissue | 6.45e-05 | 195 | 96 | 5 | 480cc62ee1e5b1aaf6b62be6e5afd7a81236a1b0 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.61e-05 | 196 | 96 | 5 | aec2b11a6048048820271266fdc8b8d806da9993 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.61e-05 | 196 | 96 | 5 | aa0dc04f94a575cd442ee473b75a4f54268e4105 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.61e-05 | 196 | 96 | 5 | 502834a16d5ada93af7ab9af0c3dc652086964bd | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.61e-05 | 196 | 96 | 5 | ae9bf04531b9bda819608d90736c4405a6c3df41 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue | 6.61e-05 | 196 | 96 | 5 | f23c33ad10f933250be98e8389a9aa278e876f96 | |
| ToppCell | Control-Lymphoid_T/NK-gd_T|Control / Disease group, lineage and cell class | 6.61e-05 | 196 | 96 | 5 | 98b11aada6bc5d928ef618573dc912d4d74a1092 | |
| ToppCell | lymphoid-T_cell-unlabelled(multiplets)|T_cell / Lineage, cell class and subclass | 6.77e-05 | 197 | 96 | 5 | f215435aee15f0ed254104bfd55670144b6d2ac3 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.93e-05 | 198 | 96 | 5 | a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.93e-05 | 198 | 96 | 5 | 85881637641d8996be2edc65c4bceff0433135e7 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.93e-05 | 198 | 96 | 5 | 76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.93e-05 | 198 | 96 | 5 | a781fd35a7cda8b7760c2e3ddccaac7aac26c979 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.93e-05 | 198 | 96 | 5 | 35499a5231818e3432cf69b5c4a58c02f7771db8 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.93e-05 | 198 | 96 | 5 | df399674345c45738d765a8354ea8d1484572c34 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.10e-05 | 199 | 96 | 5 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | mLN-ILC-ILC|mLN / Region, Cell class and subclass | 7.10e-05 | 199 | 96 | 5 | ab09a06cdea2597e9fe4b4b304655e9de4d433f6 | |
| ToppCell | mLN-ILC|mLN / Region, Cell class and subclass | 7.10e-05 | 199 | 96 | 5 | d6c299312c747fb1b7c53644c53efc03a5fffe85 | |
| ToppCell | mLN-(3)_ILC|mLN / shred on region, Cell_type, and subtype | 7.10e-05 | 199 | 96 | 5 | 00e0e2a766dd9c4d0a65f53d88fa50df4b6a3d60 | |
| ToppCell | mLN-(3)_ILC-(30)_ILC|mLN / shred on region, Cell_type, and subtype | 7.10e-05 | 199 | 96 | 5 | 33ac6d77099076df01299be429f4ba96f2f34cc1 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.27e-05 | 200 | 96 | 5 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.27e-05 | 200 | 96 | 5 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.27e-05 | 200 | 96 | 5 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-MAIT|IIF / Disease, condition lineage and cell class | 7.27e-05 | 200 | 96 | 5 | 7518bbf1c713b74f89be25ee700c6b0edc16ee8a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 7.27e-05 | 200 | 96 | 5 | 98a994692440cb4f505b050276f0c8022c814a21 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm|1m / Sample Type, Dataset, Time_group, and Cell type. | 7.27e-05 | 200 | 96 | 5 | c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.27e-05 | 200 | 96 | 5 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | MS-IIF|MS / Disease, condition lineage and cell class | 7.27e-05 | 200 | 96 | 5 | 221f59edcfc18baece13184c2552d26022228146 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-gd_T|Control / Disease, condition lineage and cell class | 7.27e-05 | 200 | 96 | 5 | 88e502c141bbb73e62aa5830d24bd645376e5f3a | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.27e-05 | 200 | 96 | 5 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 7.27e-05 | 200 | 96 | 5 | ef222dc4a205d670172dae74990bdb952ac92e5b | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 7.27e-05 | 200 | 96 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.27e-05 | 200 | 96 | 5 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 114 | 96 | 4 | 84318a25a701331ccd5e68221239c543b9c0cc54 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.20e-04 | 137 | 96 | 4 | 03e124901a0e85b59b6882bbafab568b50907e8b | |
| ToppCell | moderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.26e-04 | 138 | 96 | 4 | afefa8233c67aa744e939156bc538449bf6bd05b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.39e-04 | 140 | 96 | 4 | 7cc891d676555609add6fc7880735d948a2ad801 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Macc1_Lrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.52e-04 | 142 | 96 | 4 | d08e1880425d285c4433014fe0242ac7ff7734af | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-Trm_Th1/Th17|bone_marrow / Manually curated celltypes from each tissue | 3.03e-04 | 149 | 96 | 4 | 264fe2ceac6379b3394d2bb47ef34692e4a64559 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 3.52e-04 | 155 | 96 | 4 | b0e456c4915076e1d38282e116a6eb3230ae80dc | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1_high|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.52e-04 | 155 | 96 | 4 | cd2ccb4632713b4def3a1064599b78207e2e44c0 | |
| ToppCell | CD8+_Memory_T_cell-RSV-6|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.78e-04 | 158 | 96 | 4 | 5ae737757a49fc96bde1e57e02066f9f65654ea1 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-04 | 160 | 96 | 4 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-04 | 160 | 96 | 4 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-04 | 161 | 96 | 4 | bd520c9a1927d5d5355b4421e6b90b58bfb76a42 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-04 | 161 | 96 | 4 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-ILC3|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.06e-04 | 161 | 96 | 4 | 584e44e6048c2678eb72cd23a86f48f2466c5da4 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.16e-04 | 162 | 96 | 4 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-04 | 162 | 96 | 4 | 3a61eda548afa2a41bdf6293d1050103dc210e52 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-04 | 162 | 96 | 4 | 593939be9d38690c89c31d4c58e351de26cbf9ab | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.26e-04 | 163 | 96 | 4 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.26e-04 | 163 | 96 | 4 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-04 | 164 | 96 | 4 | 54f8f11d2fa899005530c08e7a1ee728c7b0799c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.36e-04 | 164 | 96 | 4 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 4.46e-04 | 165 | 96 | 4 | f012a27ece54c0f7b73a2f4f89c6ee8b865f8782 | |
| ToppCell | COVID-19_Mild-PLT_0|COVID-19_Mild / Disease Group and Platelet Clusters | 4.46e-04 | 165 | 96 | 4 | 083a14d3b0162cee4e79f7398b8fb739582b39ff | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.56e-04 | 166 | 96 | 4 | a7ac5a414e3e2ff01f1c452c0a85048b17cba0b6 | |
| Computational | Genes in the cancer module 257. | 1.67e-04 | 156 | 57 | 6 | MODULE_257 | |
| Drug | Niclosamide [50-65-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.28e-07 | 158 | 95 | 8 | 4136_UP | |
| Drug | pyrvinium pamoate; Up 200; 1.25uM; MCF7; HT_HG-U133A_EA | 5.73e-07 | 170 | 95 | 8 | 978_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.28e-06 | 189 | 95 | 8 | 6954_UP | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.61e-06 | 195 | 95 | 8 | 4170_DN | |
| Drug | Etodolac [41340-25-4]; Down 200; 14uM; PC3; HT_HG-U133A | 1.88e-06 | 199 | 95 | 8 | 7246_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.88e-06 | 199 | 95 | 8 | 7254_DN | |
| Drug | Syrosingopine [84-36-6]; Up 200; 6uM; MCF7; HT_HG-U133A | 9.82e-06 | 178 | 95 | 7 | 2753_UP | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.14e-05 | 182 | 95 | 7 | 848_UP | |
| Drug | Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.35e-05 | 187 | 95 | 7 | 7368_UP | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.61e-05 | 192 | 95 | 7 | 6353_UP | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.72e-05 | 194 | 95 | 7 | 3507_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A | 1.78e-05 | 195 | 95 | 7 | 1163_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; MCF7; HT_HG-U133A | 1.78e-05 | 195 | 95 | 7 | 7101_UP | |
| Drug | Boldine [476-70-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.83e-05 | 196 | 95 | 7 | 4122_DN | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; HL60; HG-U133A | 1.83e-05 | 196 | 95 | 7 | 2033_UP | |
| Drug | Thiethylperazine malate [52239-63-1]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.83e-05 | 196 | 95 | 7 | 6232_UP | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.83e-05 | 196 | 95 | 7 | 6832_UP | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 1.90e-05 | 197 | 95 | 7 | 2237_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 7391_UP | |
| Drug | rotenone; Down 200; 1uM; MCF7; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 5915_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; HL60; HG-U133A | 1.96e-05 | 198 | 95 | 7 | 2006_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 4.94e-05 | 156 | 95 | 6 | 1010_UP | |
| Drug | Pimozide [2062-78-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 6.98e-05 | 166 | 95 | 6 | 6780_UP | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 7.96e-05 | 170 | 95 | 6 | 965_UP | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 8.77e-05 | 173 | 95 | 6 | 995_UP | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.06e-04 | 179 | 95 | 6 | 5074_UP | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.30e-04 | 186 | 95 | 6 | 6793_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.34e-04 | 187 | 95 | 6 | 3943_UP | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.38e-04 | 188 | 95 | 6 | 3281_UP | |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; HL60; HG-U133A | 1.38e-04 | 188 | 95 | 6 | 1395_UP | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.42e-04 | 189 | 95 | 6 | 2231_UP | |
| Drug | troglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 1.42e-04 | 189 | 95 | 6 | 2692_DN | |
| Drug | 5253409; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 1.47e-04 | 190 | 95 | 6 | 961_UP | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.60e-04 | 193 | 95 | 6 | 3262_UP | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.60e-04 | 193 | 95 | 6 | 4670_UP | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 1.64e-04 | 194 | 95 | 6 | 4159_DN | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.64e-04 | 194 | 95 | 6 | 4738_DN | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.64e-04 | 194 | 95 | 6 | 5952_DN | |
| Drug | Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; HL60; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 1866_DN | |
| Drug | valinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 5911_DN | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 4156_DN | |
| Drug | Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 3360_UP | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 1681_UP | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 5232_UP | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 4183_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3862_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 6940_UP | |
| Drug | rotenone; Up 200; 1uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 5915_UP | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3439_DN | |
| Drug | Meticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 1671_DN | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3555_UP | |
| Drug | Brompheniramine maleate [980-71-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 4131_UP | |
| Drug | Boldine [476-70-0]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 2148_DN | |
| Drug | Dimethadione [695-53-4]; Down 200; 31uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 5668_DN | |
| Drug | Pirenperone [ 75444-65-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 5274_UP | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 3359_UP | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 5013_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 3944_DN | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 5429_UP | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; HL60; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 2159_DN | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 2065_UP | |
| Drug | Ampicillin trihydrate [7177-48-2]; Up 200; 10uM; HL60; HG-U133A | 1.83e-04 | 198 | 95 | 6 | 2030_UP | |
| Drug | Natamycin [7681-93-8]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 3548_UP | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; PC3; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 3739_UP | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; HL60; HG-U133A | 1.83e-04 | 198 | 95 | 6 | 1985_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 2683_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.94e-04 | 200 | 95 | 6 | 4379_DN | |
| Drug | ATN-2 | 2.56e-04 | 6 | 95 | 2 | CID003081684 | |
| Disease | dentatorubral-pallidoluysian atrophy (implicated_via_orthology) | 1.03e-05 | 2 | 95 | 2 | DOID:0060162 (implicated_via_orthology) | |
| Disease | fear of minor pain measurement | 1.36e-04 | 31 | 95 | 3 | EFO_0008340 | |
| Disease | body surface area | 2.33e-04 | 643 | 95 | 9 | EFO_0022196 | |
| Disease | coffee consumption measurement | 3.13e-04 | 182 | 95 | 5 | EFO_0006781 | |
| Disease | opioid use disorder | 3.24e-04 | 101 | 95 | 4 | EFO_0010702 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 3.64e-04 | 9 | 95 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | smoking cessation | 6.51e-04 | 325 | 95 | 6 | EFO_0004319 | |
| Disease | cognitive function measurement | MST1R POU6F2 KMT2D FAM120A SEMA6D GLI3 BARHL2 PER1 AUTS2 RIMBP2 KMT2E BHLHE40 WNK2 | 6.81e-04 | 1434 | 95 | 13 | EFO_0008354 |
| Disease | Coffin-Siris syndrome | 7.82e-04 | 13 | 95 | 2 | C0265338 | |
| Disease | smoking behavior | 8.36e-04 | 341 | 95 | 6 | EFO_0004318 | |
| Disease | age at last pregnancy measurement | 9.10e-04 | 14 | 95 | 2 | EFO_0009440 | |
| Disease | unipolar depression, mood disorder | 9.40e-04 | 134 | 95 | 4 | EFO_0003761, EFO_0004247 | |
| Disease | platelet crit | KLHL29 FOXO1 CSRNP1 ARHGEF40 U2SURP YLPM1 RERE MEF2D PKN3 CABLES1 | 9.90e-04 | 952 | 95 | 10 | EFO_0007985 |
| Disease | Lymphoma, Large-Cell, Follicular | 1.05e-03 | 15 | 95 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 1.05e-03 | 15 | 95 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 1.05e-03 | 15 | 95 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 1.05e-03 | 15 | 95 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 1.05e-03 | 15 | 95 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 1.05e-03 | 15 | 95 | 2 | C1956130 | |
| Disease | response to methotrexate | 1.20e-03 | 16 | 95 | 2 | GO_0031427 | |
| Disease | digit length ratio | 1.20e-03 | 16 | 95 | 2 | EFO_0004841 | |
| Disease | Abnormality of refraction | 1.50e-03 | 673 | 95 | 8 | HP_0000539 | |
| Disease | Cannabis use initiation | 1.52e-03 | 18 | 95 | 2 | EFO_0007586 | |
| Disease | noggin measurement | 1.52e-03 | 18 | 95 | 2 | EFO_0021995 | |
| Disease | cancer (implicated_via_orthology) | 1.77e-03 | 268 | 95 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 1.85e-03 | 75 | 95 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Lymphoma, Follicular | 1.88e-03 | 20 | 95 | 2 | C0024301 | |
| Disease | dyslexia | 1.89e-03 | 162 | 95 | 4 | EFO_0005424 | |
| Disease | chronotype measurement | 2.17e-03 | 882 | 95 | 9 | EFO_0008328 | |
| Disease | alcohol drinking | 2.30e-03 | 81 | 95 | 3 | EFO_0004329 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.38e-03 | 566 | 95 | 7 | EFO_0007660, EFO_0008354 | |
| Disease | response to selective serotonin reuptake inhibitor | 2.38e-03 | 82 | 95 | 3 | EFO_0005658 | |
| Disease | alcoholic liver disease | 2.38e-03 | 82 | 95 | 3 | EFO_0008573 | |
| Disease | depressive symptom measurement | 2.58e-03 | 426 | 95 | 6 | EFO_0007006 | |
| Disease | cortical thickness | 3.11e-03 | 1113 | 95 | 10 | EFO_0004840 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSLHDSSPPPLSGQP | 161 | Q96P26 | |
| NQLSGASPPHPPTTP | 6 | Q5W0A0 | |
| PSLQPPHPGSSTPTL | 1481 | Q8TER5 | |
| AAIVPPPSVQGHPFP | 106 | A8MYA2 | |
| LISSPFLGPHPHQPP | 306 | O14503 | |
| PSAPPPANFPHVTPN | 286 | P54259 | |
| SFHLSPRGPPTSEPP | 336 | P78314 | |
| APTFPPHPVVFLPGT | 206 | Q6P575 | |
| DLLPGSPFHVALPPP | 386 | Q9BQC3 | |
| ILPPGHSHPDPTPQS | 1246 | O14529 | |
| PLPSHLDLPSFAPPA | 1001 | Q2TAZ0 | |
| PGSPASTQPPPLHFS | 881 | Q7Z5Q5 | |
| HPVPTQSPLPFTQPG | 496 | Q96EV2 | |
| PPGAIPPALHLNPAF | 281 | Q8N684 | |
| PPALHLNPAFFPPPN | 286 | Q8N684 | |
| GQSTPSPHLVPSPAP | 1076 | Q9H3S7 | |
| LPSQTPGHSLTPPPS | 626 | Q8TB72 | |
| PNSSLLGHPFPPSVP | 241 | Q86TB9 | |
| VLPPGTSHFTPPQTP | 766 | Q8WXD9 | |
| DAHLPPPPTLSSGSP | 436 | Q96DN6 | |
| IHPAPTFPTQRPIPG | 381 | P10071 | |
| NIEAPHFPLPGLSPP | 531 | Q96S65 | |
| LAPSPPHRPDSPLFN | 961 | O15534 | |
| LPAQLALPHPPAGPF | 86 | P52945 | |
| PPPLPLTGAHRFSAP | 36 | Q9ULL4 | |
| PPPNSSSSVHPGPLA | 1006 | Q8WXX7 | |
| LLPGPGPAHSPQPSK | 991 | Q8TDM6 | |
| GPPLFPSSAHPTVPP | 1746 | Q8IZD2 | |
| SGPLSHPTPLSAPPS | 621 | P35658 | |
| APLPLPSPTSPGFQF | 81 | Q6ZTU2 | |
| PPPQATLPTSGHAPA | 151 | P41161 | |
| QSHTLPFPPPPALPF | 851 | Q9NZB2 | |
| PLLQSFTLPHQPAPP | 766 | Q6NV74 | |
| PAQHFGPRLPSPDPT | 121 | C9JE40 | |
| QGHPLPKSFSSPPSP | 956 | Q5T0Z8 | |
| VPPPASQHSTPAGLP | 376 | Q8TES7 | |
| LSQHPPVPPAAAGPL | 131 | Q12778 | |
| PFHGSSPPQSTPLSP | 1776 | Q9H7D0 | |
| PQPSSLPPLIPGGHA | 141 | Q8TDN4 | |
| PLLPGLSFHQPPQQP | 76 | Q8NE35 | |
| LIPSHPSSFGSPPHP | 261 | Q96PV7 | |
| PSSFGSPPHPHLLPT | 266 | Q96PV7 | |
| GAPPVIQPLPAFAHP | 161 | Q15811 | |
| PLPPASNPPGTVHSA | 891 | Q86UU0 | |
| PSPTPLGSNIPLHPN | 1176 | Q86UU0 | |
| PALNPLSSPIPGTPH | 371 | Q9NY43 | |
| PVRPGHYPASSPTNP | 921 | Q12840 | |
| VPNHLPLPGPPFSFQ | 241 | Q5T7N3 | |
| LPSERHSLPQGPPSP | 726 | Q9UJ99 | |
| HSPGGQPFPTLPSKP | 481 | Q8NBF1 | |
| PGPSSSPSLPHQAPL | 771 | Q9NZM4 | |
| APGASTQPPPHLPTK | 1231 | Q9NZM4 | |
| SPPPPTHSTQLGAPS | 251 | Q14814 | |
| HRPPGPLFSSSDPLP | 821 | A6NNC1 | |
| EFTGLPPALTPPAPH | 851 | Q6P5Z2 | |
| PPNPHLIIPTPEGFS | 1161 | Q9Y6R4 | |
| QHPPPLAQPALSPAS | 321 | P35716 | |
| PHPRPAPQSKPLASS | 591 | O15034 | |
| PAPGAPSPPATLAHL | 56 | P41225 | |
| AHISPAQGSPKPPPA | 106 | P19484 | |
| HPPTLPPSAPLQFLT | 331 | Q9H0F5 | |
| HQPPFFPALTLPPNG | 36 | O15119 | |
| PRTLNGVSSPPHPSP | 391 | Q9BZL4 | |
| GLPPSHSSPSLQPKP | 986 | A5PKW4 | |
| PPLSPFPHIKQQPGS | 961 | P28749 | |
| HSGSPTYLQLPPRPP | 326 | Q9H4M7 | |
| GPSHPAQPKAPRFPS | 241 | Q86WR7 | |
| VNPPLPTTFQPGAPH | 196 | O95486 | |
| HPPFPVGPQPLLTAQ | 86 | P78424 | |
| SPPQKPSQSPGHGLP | 271 | P78424 | |
| GHGLPSPLTPPNPLQ | 281 | P78424 | |
| HLLQAPFSPPPSPPV | 881 | Q9H6K5 | |
| VFPPSPQPHGPLASS | 241 | Q6ZUB1 | |
| SPTPPKLSPGQLSPH | 171 | Q8N8Z3 | |
| PPTGLHQVAPQPPFA | 1021 | Q9P2R6 | |
| HHLPFAPGTLPPPNL | 1121 | Q8TAQ2 | |
| QASPPHPCRFLLGPP | 1026 | Q8IY92 | |
| LTPGLPYPHQTPQGL | 781 | Q9BXP5 | |
| EHTLPPPPSGLPFNA | 371 | O15042 | |
| SPQAHSYPGPPLAAP | 116 | Q6ZRI6 | |
| PHHQPSPAPLTLSAP | 386 | Q5JTD0 | |
| HGPPPSKVLPFPSQV | 91 | Q9Y2C2 | |
| PQQGSPHSLPPPLTL | 41 | Q8WVN8 | |
| PSPSLSPSPLHGIFQ | 216 | Q96EK2 | |
| GPHSAPPTAPSPFLF | 456 | P21580 | |
| NLSPAPHLASGSPPP | 296 | Q9C0H9 | |
| AFLPTTHSPPGPQQP | 821 | Q9HBL0 | |
| GVSTPSPPHPQASPK | 226 | Q9H8N7 | |
| GPPPSVITFAHPAPS | 466 | Q9P1Z0 | |
| PPPPPTHTVQHEGFL | 2411 | Q9H254 | |
| PPTTYHPPLQSAGPS | 681 | P49750 | |
| QGLPSPPGTPHSPSY | 671 | Q9ULC8 | |
| APEPSPHSGTPQPAL | 1516 | Q9Y3S1 | |
| PLPPNVGFFHTAPPT | 1966 | Q9Y3S1 | |
| SPAQPASPHPVGLAP | 576 | Q6UX68 | |
| PQFFPSSPPPHSPLS | 806 | Q8NFY4 | |
| PYSPSPSLPVGPTAH | 206 | A5D8V6 | |
| SIAFPLANPPVAPHP | 1236 | Q92547 | |
| HFQSKLITPPPPPPS | 26 | Q96HE9 | |
| AVLPPTLPQPASHFP | 171 | Q96HE9 | |
| GFRFLPPPHPPSANL | 856 | Q04912 | |
| VFSPPQASPPQPSHG | 581 | O75385 | |
| PGHYSLPQPPSQPLS | 201 | Q96CT2 | |
| PGTPRHQPSTPDPFL | 2231 | O14686 | |
| DFGPPAPPLLHTPQT | 1781 | Q9NR99 | |
| PPSAPHPNDLSGPSV | 126 | Q9NZM1 |